(Q48122815)

English

Sequential administration of temozolomide and fotemustine: depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours.

scientific article published in July 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Sequential administration of temozolomide and fotemustine: depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

0 references

Maurizio D'Incalci

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Laurent Arthur Decosterd

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Gennaro Colella

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

author name string

M Gander

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

S Leyvraz

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

M Bonfanti

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

C Marzolini

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

F Shen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

D Liénard

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

L Perey

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

J Biollaz

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

F Lejeune

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

D Yarosh

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

M Belanich

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 July 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

831-838

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of the DNA repair enzyme O6-alkyl guanine alkyltransferase (AT) in cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between O6-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N'-nitro-N-nitrosoguanidine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

O6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of mammalian O6-alkylguanine-DNA alkyltransferase in a cell line sensitive to alkylating agents

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretreatment of human colon tumor cells with DNA methylating agents inhibits their ability to repair chloroethyl monoadducts.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the hepatic O6-alkylguanine-DNA alkyltransferase in vivo by pretreatment with antineoplastic agents

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity and unexpected lung toxicity of the sequential administration of two alkylating agents--dacarbazine and fotemustine--in patients with melanoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosage and cycle effects of dacarbazine (DTIC) and fotemustine on O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferase

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of O6-alkylguanine alkyltransferase-directed DNA repair in metastatic colon cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

O6-methylguanine-DNA methyltransferase activities in biopsies of human melanoma tumours

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findings

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008304032421

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008304032421

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470431%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48122815&oldid=1448058237"